Primary Prevention of Cardiovascular and Heart Failure Events With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Their Combination in Type 2 Diabetes.
Diabetes Care. 2022 Apr 1;45(4):909-918. doi: 10.2337/dc21-1113.
Diabetes Care. 2022.
PMID: 35100355